David Hansoe Heredero-Jung

David Hansoe Heredero-Jung
  • Bachelor of Medicine
  • Hospital Universitario de Salamanca

About

11
Publications
1,890
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
27
Citations
Introduction
Laboratory Medicine. PhD Student - Molecular Genetics in Allergology Master Student - Precision Oncology, Genomics and Big Data
Current institution
Hospital Universitario de Salamanca
Additional affiliations
June 2020 - August 2020
Complejo Hospitalario Universitario de Santiago
Position
  • Professor
May 2017 - present
Hospital Universitario de Salamanca
Position
  • Medical Doctor
July 2014 - July 2014
Hamamatsu University School of Medicine
Position
  • Researcher
Education
September 2009 - June 2015
Autonomous University of Madrid
Field of study

Publications

Publications (11)
Article
Full-text available
One of the most critical goals in healthcare is safe and effective drug therapy, which is directly related to an individual’s response to treatment. Precision medicine can improve drug safety in many scenarios, including polypharmacy, and it requires the development of new genetic characterization methods. In this report, we use real-time PCR, micr...
Article
Full-text available
Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP) affects the quality of life of patients suffering from it. The search for a suitable biomarker has been conducted over the last decades. Interleukin 5 receptor subunit alpha (IL-5Rα) involves the activation, maintenance, and survival of eosinophils, which are highly tied to chronic inflammatory p...
Article
Full-text available
Background: Hemolysis is the most common type of preanalytical interference. Cut-offs based on the hemolysis index level can be established using different approaches. The Working Group for Preanalytical Phase of the European Federation of Laboratory Medicine has developed a protocol for hemolysis management based on cut-offs estimated from biolog...
Article
Full-text available
Background: Asthma is a heterogeneous syndrome with a broad clinical spectrum and high drug response variability. The inflammatory response in asthma involves multiple effector cells and mediator molecules. Based on asthma immunopathogenesis, precision medicine can be a promising strategy for identifying biomarkers. Biologic therapies acting on the...
Conference Paper
Full-text available
Background: Asthma is a heterogeneous syndrome with a broad clinical spectrum and high drug response variability. The inflammatory response in asthma involves multiple effector cells andmediatormolecules. Based on asthma immunopathogenesis, precision medicine can be a promising strategy for identifying biomarkers. Biologic therapies acting on the I...

Network

Cited By